相似文献
1
Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.
Antimicrob Agents Chemother. 2009 Jan;53(1):256-60. doi: 10.1128/AAC.00470-08. Epub 2008 Sep 22.
2
Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.
Antimicrob Agents Chemother. 2007 Jan;51(1):154-61. doi: 10.1128/AAC.00478-06. Epub 2006 Oct 30.
3
Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.
Antimicrob Agents Chemother. 2006 Jan;50(1):324-31. doi: 10.1128/AAC.50.1.324-331.2006.
4
Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.
PLoS One. 2013 Sep 27;8(9):e77031. doi: 10.1371/journal.pone.0077031. eCollection 2013.
5
Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3.
Eukaryot Cell. 2011 Feb;10(2):272-5. doi: 10.1128/EC.00133-10. Epub 2010 Dec 3.
6
Human β-defensin 2 kills through phosphatidylinositol 4,5-bisphosphate-mediated membrane permeabilization.
Sci Adv. 2018 Jul 25;4(7):eaat0979. doi: 10.1126/sciadv.aat0979. eCollection 2018 Jul.
7
Antimicrobial activity of human β-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.
Peptides. 2012 Dec;38(2):255-65. doi: 10.1016/j.peptides.2012.08.024. Epub 2012 Sep 19.
8
Interaction of antibacterial peptides spanning the carboxy-terminal region of human beta-defensins 1-3 with phospholipids at the air-water interface and inner membrane of E. coli.
Peptides. 2008 Jan;29(1):7-14. doi: 10.1016/j.peptides.2007.10.015. Epub 2007 Oct 24.
9
Human β defensins-1, an antimicrobial peptide, kills Candida glabrata by generating oxidative stress and arresting the cell cycle in G0/G1 phase.
Biomed Pharmacother. 2022 Oct;154:113569. doi: 10.1016/j.biopha.2022.113569. Epub 2022 Aug 18.
10
Human beta-defensins: differential activity against candidal species and regulation by Candida albicans.
J Dent Res. 2005 May;84(5):445-50. doi: 10.1177/154405910508400509.
引用本文的文献
1
Antifungal Innate Immunity.
Adv Exp Med Biol. 2025;1476:225-250. doi: 10.1007/978-3-031-85340-1_9.
2
Natural and induced immune responses in oral cavity and saliva.
BMC Immunol. 2025 Apr 18;26(1):34. doi: 10.1186/s12865-025-00713-8.
3
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.
Pharmaceuticals (Basel). 2025 Mar 4;18(3):364. doi: 10.3390/ph18030364.
4
The Contribution of Human Antimicrobial Peptides to Fungi.
Int J Mol Sci. 2025 Mar 11;26(6):2494. doi: 10.3390/ijms26062494.
5
Therapeutic potential of mesenchymal stem cells for fungal infections: mechanisms, applications, and challenges.
Front Microbiol. 2025 Jan 30;16:1554917. doi: 10.3389/fmicb.2025.1554917. eCollection 2025.
6
β-Defensin-1 Regulates Influenza Virus Infection in Human Bronchial Epithelial Cells through the STAT3 Signaling Pathway.
Pathogens. 2023 Jan 11;12(1):123. doi: 10.3390/pathogens12010123.
7
Role of Vaginal Mucosa, Host Immunity and Microbiota in Vulvovaginal Candidiasis.
Pathogens. 2022 May 25;11(6):618. doi: 10.3390/pathogens11060618.
8
Expression of anti-fungal peptide, β-defensin 118 in oral fibroblasts induced by C. albicans β-glucan-containing particles.
J Appl Oral Sci. 2022 Apr 29;30:e20210321. doi: 10.1590/1678-7757-2021-0321. eCollection 2022.
9
Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19.
Infect Dis Ther. 2022 Feb;11(1):53-78. doi: 10.1007/s40121-021-00559-8. Epub 2021 Nov 22.
10
Membrane-Interacting Antifungal Peptides.
Front Cell Dev Biol. 2021 Apr 12;9:649875. doi: 10.3389/fcell.2021.649875. eCollection 2021.
本文引用的文献
1
Human defensins: synthesis and structural properties.
Curr Pharm Des. 2007;13(30):3096-118. doi: 10.2174/138161207782110381.
2
Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs.
J Biol Chem. 2007 Jul 6;282(27):19653-65. doi: 10.1074/jbc.M611003200. Epub 2007 Apr 23.
3
Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.
Antimicrob Agents Chemother. 2007 Jan;51(1):154-61. doi: 10.1128/AAC.00478-06. Epub 2006 Oct 30.
4
Human beta-defensin-3: a promising antimicrobial peptide.
Mini Rev Med Chem. 2006 Oct;6(10):1063-73. doi: 10.2174/138955706778560193.
5
Host antimicrobial defence peptides in human disease.
Curr Top Microbiol Immunol. 2006;306:67-90. doi: 10.1007/3-540-29916-5_3.
6
Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
Peptides. 2006 Nov;27(11):2607-13. doi: 10.1016/j.peptides.2006.06.004. Epub 2006 Jul 24.
7
Human beta-defensins.
Cell Mol Life Sci. 2006 Jun;63(11):1294-313. doi: 10.1007/s00018-005-5540-2.
8
Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system.
J Pept Sci. 2006 Apr;12(4):243-57. doi: 10.1002/psc.749.
9
Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines.
Antimicrob Agents Chemother. 2005 Nov;49(11):4561-6. doi: 10.1128/AAC.49.11.4561-4566.2005.
10
Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.
Biochemistry. 2005 Jul 19;44(28):9804-16. doi: 10.1021/bi050272k.
Zotero 插件